Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hyundai Bioland, formerly known as SK BioLand, is a prominent South Korean biotechnology company specializing in the development and manufacture of natural ingredients for the cosmetic, pharmaceutical, and health supplement industries. The company is a leader in tissue engineering, producing a range of medical devices including collagen-based wound dressings, dental membranes, and bone graft substitutes. Following its acquisition by the Hyundai Department Store Group in 2020, the company has strengthened its focus on premium health functional foods and regenerative medicine. Its product portfolio includes high-purity hyaluronic acid and various botanical extracts used in dermatological and orthopedic applications. Hyundai Bioland operates multiple manufacturing facilities and R&D centers dedicated to advancing natural product chemistry and regenerative therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SK BioLand.